by CN Bio. | Dec 7, 2021 | Blog, OOC Blog
The liver is responsible for metabolizing most medications, and as such represents one of the primary tissues affected by adverse drug reactions. Drug-induced liver injury (DILI) is a potential complication of nearly all classes of medication. Unfortunately,...
by CN Bio. | Jul 15, 2021 | OOC Blog
The aim of organ-on-a-chip (OOC) technology is to more accurately replicate human physiology in vitro to overcome the relevance limitations of current approaches, and the field is progressing at a rapid pace! Many hundreds of academic researchers are choosing to work...
by CN Bio. | Feb 17, 2021 | OOC Blog
How Mimicking Blood Flow Makes Organ-on-a-Chip Technology Even More Life-like With every beat of your heart, blood rushes through your body. Some floods your arteries traveling from the lungs back to the heart. Some squeezes almost single-file, one frisbee-shaped...
by CN Bio. | Jan 11, 2021 | OOC Blog
How a Partnership between the FDA and Organ-on-a-Chip Developers Has the Potential to Fast-track Drug Development From a small discovery in a research lab to a capsule on a pharmacist’s shelf – the path of drug development is a long one. Whilst scientists discover or...
